MRM Wins Novartis Aclasta European CRM Business

Share this article:
Novartis tapped MRM Worldwide, an interactive and relationship marketing company, to undertake European patient communications for its Aclasta CRM program, it was announced yesterday.


Aclasta is an annual infusion for the treatment of Paget's disease and is in the third phase of clinical trials for other metabolic bone disorders such as osteoporosis.


Novartis said it also is considering letting MRM Worldwide pitch for all of its global CRM opportunities.


MRM Partners, a unit of McCann Worldgroup, which is owned by Interpublic Group of Companies, has 62 offices in 37 countries, more than 1,700 employees and clients such as Coca-Cola, Dell, General Motors, Intel, Royal Bank of Scotland Group, Tesco, UPS, Unilever and Vodafone.


Share this article:
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

Top 5 Spending and Investment Insights from Marketers

Top 5 Spending and Investment Insights from Marketers

Confidence in data-driven marketing led marketers to set high Q1 2014 goals.

MeritDirect Introduces Predictive Marketing Suite

MeritDirect Introduces Predictive Marketing Suite

New solutions include next logical product and customer lookalike modeling. The long-time direct marketing player announces it will open a San Jose office in September.

App of the Week: Refresh

App of the Week: Refresh

Cool or creepy? Refresh provides data that aims to help marketers and salespeople spark relevant in-person customer conversations.